The Integrated Technology Resource for Biomedical Glycomics at the University of Georgia is focused on developing technologies and tools for the biomedical community to facilitate the study of glycomics: the glycans, glycoconjugates, proteins that regulate their expression, and proteins that recognize them. The platform the Resource has chosen to drive glycomics technology development is that of stem cell differentiation in vitro. One of the most promising areas of biomedical research is in the differentiation of stem cells into cell types that can be developed for the treatment of various diseases, such as diabetes. As differentiation is directed in culture, there is a critical need for the development of specific cell surface markers to enable separation of target cell populations. Since cells are covered with glycans, and glycan expression is known to change during differentiation and in many diseases such as cancer, they are prime targets for cell marker discovery. The technologies of the Resource have allowed significant progress in identifying specific changes in cellular glycan expression during mouse stem cell differentiation. During the next funding cycle, the Resource will transition into human stem cells, both embryonic and adult. Through its own Core 1 Human Stem Cell Platform and Collaborative Projects, several types of cells will be analyzed. Core 2, Glycoprotein and Glycolipid Analysis, will focus on increasing the sensitivities of glycan identification and quantitation such that <105 cells can be analyzed, opening the door for the use of clinical tissue samples. In addition, this Core will also focus on methods for elucidating the site-specific glycosylation of glycoproteins, a novel method for studying glycan biosynthesis using metabolic isotopic labeling of glycans, and glycosphingolipid expression. Core 3, Glycotranscriptome, will continue to develop methods for RTPCR quantitation of glycogene transcripts (mouse and human) and elucidating glycan biosynthetic pathways. Core 4, Bioinformatics, will extend its programs to allow integration of glycan and transcript expression to allow a comprehensive picture of the changes of the glycome during differentiation and means to visualize and query the data. In addition, it will expand its CLYDE II protocol that allows various carbohydrate databases from around the world to communicate. The Analytical Service and Training Program of the Resource analyzes samples from across the U.S., has added glycotranscriptome analysis, and is expanding to include glycosaminoglycans analysis. Several workshops on various aspects of glycan analysis are offered each year. Technologies from the Resource are having an impact on stem cell medicine, as well as the development of biomarkers for specific types of cancer and for other diseases such as Type 2 diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Biotechnology Resource Grants (P41)
Project #
8P41GM103490-10
Application #
8300222
Study Section
Special Emphasis Panel (ZRG1-CB-L (40))
Program Officer
Sheeley, Douglas
Project Start
2003-09-01
Project End
2013-05-31
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
10
Fiscal Year
2012
Total Cost
$1,686,251
Indirect Cost
$600,117
Name
University of Georgia
Department
Type
Organized Research Units
DUNS #
004315578
City
Athens
State
GA
Country
United States
Zip Code
30602
Carroll, Daniela J; O'Sullivan, Jeremy A; Nix, David B et al. (2018) Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating ?2-integrin-dependent function in human eosinophils. J Allergy Clin Immunol 141:2196-2207
Middleton, Dustin R; Zhang, Xing; Wantuch, Paeton L et al. (2018) Identification and characterization of the Streptococcus pneumoniae type 3 capsule-specific glycoside hydrolase of Paenibacillus species 32352. Glycobiology 28:90-99
Selvan, Nithya; George, Stephan; Serajee, Fatema J et al. (2018) O-GlcNAc transferase missense mutations linked to X-linked intellectual disability deregulate genes involved in cell fate determination and signaling. J Biol Chem 293:10810-10824
King, Samuel R; Hecht, Elizabeth S; Muddiman, David C (2018) Demonstration of hydrazide tagging for O-glycans and a central composite design of experiments optimization using the INLIGHT™ reagent. Anal Bioanal Chem 410:1409-1415
Chen, Yu; Bensing, Barbara A; Seepersaud, Ravin et al. (2018) Unraveling the sequence of cytosolic reactions in the export of GspB adhesin from Streptococcus gordonii. J Biol Chem 293:5360-5373
Gas-Pascual, Elisabet; Ichikawa, Hiroshi Travis; Sheikh, Mohammed Osman et al. (2018) CRISPR/Cas9 and glycomics tools for Toxoplasma glycobiology. J Biol Chem :
Saeui, Christopher T; Nairn, Alison V; Galizzi, Melina et al. (2018) Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes. PLoS One 13:e0195812
Spiciarich, David R; Oh, Stephen T; Foley, Amy et al. (2018) A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia. Cancer Res 78:6762-6770
Ferreira, Carlos R; Xia, Zhi-Jie; Clément, Aurélie et al. (2018) A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan Glycosylation. Am J Hum Genet 103:553-567
Talabnin, Krajang; Talabnin, Chutima; Ishihara, Mayumi et al. (2018) Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma. Oncol Lett 15:1030-1036

Showing the most recent 10 out of 147 publications